State Street Corp Arrowhead Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.8 Trillion
Q3 2025

A detailed history of State Street Corp transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 6,397,364 shares of ARWR stock, worth $264 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,397,364

Previous 6,371,056 0.41%

Holding current value

$264 Million

Previous $101 Million 119.19%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$14.71 - $34.49 $386,990 - $907,362	26,308 Added 0.41%	6,397,364 $221 Million
Q2 2025 Aug 14, 2025	SELL	$9.99 - $16.97 $6.28 Million - $10.7 Million	-628,193 Reduced 8.98%	6,371,056 $101 Million
Q1 2025 May 15, 2025	BUY	$12.74 - $21.53 $12.5 Million - $21.2 Million	983,022 Added 16.34%	6,999,249 $89.2 Million
Q4 2024 Feb 14, 2025	SELL	$17.7 - $26.34 $5.98 Million - $8.91 Million	-338,104 Reduced 5.32%	6,016,227 $113 Million
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $10 Million - $15.3 Million	516,569 Added 8.85%	6,354,331 $123 Million

Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $15.8 Million - $20.4 Million	-722,941 Reduced 11.02%	5,837,762 $152 Million
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $7.19 Million - $10.4 Million	-264,408 Reduced 3.87%	6,560,703 $188 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $20.4 Million - $29.9 Million	962,146 Added 16.41%	6,825,111 $209 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $9.31 Million - $12.8 Million	355,394 Added 6.45%	5,862,965 $158 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $9.94 Million - $16.4 Million	-395,197 Reduced 6.7%	5,507,571 $196 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $1.6 Million - $2.6 Million	-67,576 Reduced 1.13%	5,902,768 $150 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $20 Million - $29 Million	715,912 Added 13.62%	5,970,344 $242 Million
Q3 2022 Nov 15, 2022	SELL	$29.63 - $48.31 $9.73 Million - $15.9 Million	-328,314 Reduced 5.88%	5,254,432 $174 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $25 Million - $45.6 Million	900,791 Added 19.24%	5,582,746 $197 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $30.8 Million - $54.4 Million	777,184 Added 19.9%	4,681,955 $215 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $1.53 Million - $2.18 Million	-26,397 Reduced 0.67%	3,904,771 $259 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $20.1 Million - $29.3 Million	344,837 Added 9.62%	3,931,168 $245 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $9.19 Million - $13.3 Million	-147,789 Reduced 3.96%	3,586,331 $297 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $12.1 Million - $17.9 Million	-197,895 Reduced 5.03%	3,734,120 $248 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $26.8 Million - $52.2 Million	-611,109 Reduced 13.45%	3,932,015 $302 Million
Q3 2020 Nov 10, 2020	SELL	$33.21 - $51.27 $11.6 Million - $17.9 Million	-348,323 Reduced 7.12%	4,543,124 $196 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $15.6 Million - $25.8 Million	596,773 Added 13.9%	4,891,447 $211 Million
Q1 2020 May 11, 2020	BUY	$20.56 - $63.12 $88.3 Million - $271 Million	4,294,674 New	4,294,674 $124 Million

Others Institutions Holding ARWR

# of Institutions

339

Shares Held

103M

Call Options Held

953K

Put Options Held

263K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Arrowhead Pharmaceuticals, Inc. Transaction History